Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: Identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action

被引:51
作者
Biswas, Swati [1 ]
Zhang, Suhong [1 ]
Fernandez, Fernando [1 ]
Ghosh, Balaram [1 ]
Zhen, Juan [2 ]
Kuzhikandathil, Eldo [3 ]
Reith, Maarten E. A. [2 ]
Dutta, Aloke K. [1 ]
机构
[1] Wayne State Univ, Dept Pharmaceut Sci, Applebaum Coll Pharm & Hlth Sci, Detroit, MI 48202 USA
[2] NYU, Sch Med, Millhauser Lab, Dept Psychiat, New York, NY 10016 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
关键词
D O I
10.1021/jm070860r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This paper describes an extended structure-activity relationships study of aminotetralin-piperazine-based hybrid molecules developed earlier for dopamine D2/D3 receptors. Various analogues as positional isomers have been developed where location of,the phenolic hydroxyl group has been varied on the aromatic ring. Between two catechol derivatives, compound 6e with a two methylene linker length exhibited higher affinity and selectivity for D3 over D2 receptors over compound 6f with four methylene linkers (D2/D3 = 50.6 vs 7.51 for 6e and 6f, respectively). In general, the (-)-isomer was more potent than the (+)-isomeric counterpart. Binding results indicated highest selectivity for D3 receptors in compound (-)-10 (K-i = 0.35 nM; D2/D3 = 71). In the 5-hydroxy series, highest selectivity for D3 receptors was exhibited by compound (-)-25 (K-i = 0.82 nM; D2/D3 = 31.5). Most potent compounds exhibited binding and functional affinities at the sub-nanomolar level for the D3 receptor. Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors by using tritiated spiperone as radioligand for competition studies to evaluate inhibition constants (K-i). A functional assay of selected compounds for stimulating GTP gamma S binding was carried out with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors. The functional assay results indicated partial to full agonist characteristics of test compounds. Compound (-)25 was selected further for in vivo study to evaluate its potency in producing contralateral rotations in rats with unilateral lesion in the nigrostriatal region induced by neurotoxin 6-OHDA, a Parkinsonian animal model. Compound (-)-25 at 5 mu mol/kg exhibited rotational activity that lasted beyond 12 h, whereas at a 1 mu mol/kg dose the rotations lasted beyond 8 h.
引用
收藏
页码:101 / 117
页数:17
相关论文
共 55 条
[1]   Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor [J].
Avenell, KY ;
Boyfield, I ;
Hadley, MS ;
Johnson, CN ;
Nash, DJ ;
Riley, GJ ;
Stemp, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (18) :2715-2720
[2]   Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease [J].
Bennett, JP ;
Piercey, MF .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :25-31
[3]   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies [J].
Bezard, E ;
Brotchie, JM ;
Gross, CE .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (08) :577-588
[4]   Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function [J].
Bézard, E ;
Ferry, S ;
Mach, U ;
Stark, H ;
Leriche, L ;
Boraud, T ;
Gross, C ;
Sokoloff, P .
NATURE MEDICINE, 2003, 9 (06) :762-767
[5]  
Bidlack Jean M., 2003, V237, P135
[6]   The structural evolution of dopamine D3 receptor ligands:: Structure-activity relationships and selected neuropharmacological aspects [J].
Boeckler, Frank ;
Gmeiner, Peter .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (01) :281-333
[7]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[8]   Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands:: Inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors [J].
Campiani, G ;
Butini, S ;
Trotta, F ;
Fattorusso, C ;
Catalanotti, B ;
Aiello, F ;
Gemma, S ;
Nacci, V ;
Novellino, E ;
Stark, JA ;
Cagnotto, A ;
Fumagalli, E ;
Carnovali, F ;
Cervo, L ;
Mennini, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) :3822-3839
[9]   CEREBRAL DOPAMINE AGONIST PROPERTIES OF SOME 2-AMINOTETRALIN DERIVATIVES AFTER PERIPHERAL AND INTRACEREBRAL ADMINISTRATION [J].
CANNON, JG ;
LEE, T ;
GOLDMAN, HD ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (09) :1111-1116
[10]   Neuroprotective effects of D3 dopamine receptor agonists [J].
Carvey, PM ;
McGuire, SO ;
Ling, ZD .
PARKINSONISM & RELATED DISORDERS, 2001, 7 (03) :213-223